<DOC>
	<DOCNO>NCT02240043</DOCNO>
	<brief_summary>The aim study evaluate growth hormone ( GH ) adrenocorticotrophic hormone ( ACTH ) secretion elderly without hypothalamic-pituitary disease use glucagon stimulation test ( use Glucagen® Hypokit , Novo Nordisk A/S , Denmark ) evaluate parameter sarcopenia , nutritional state , bone mineral density , frailty criterion secretion GH .</brief_summary>
	<brief_title>Growth Hormone Evaluation Elderly People</brief_title>
	<detailed_description>subject 65 year old recruit geriatric ambulatory unit hospital voluntarily participate research study concern GH ACTH axis elderly , include realization glucagon stimulation test first phase study . The GST ( Glucagen® Hypokit , Novo Nordisk A/S , Denmark ) choose test ass ACTH GH release know contraindication mild side effect . It provocative test evaluate GH ACTH axis , i.e , diagnostic test , without therapeutic effect .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<criteria>elderly people 65 year old comorbidities peculiar age ( hypertension , diabetes , dyslipidemia , parkinson disease ) without comorbidities pituitary disease , severe acute disease , terminal renal chronic disease , active malignant cancer , presence disease could interfere somatotrophic axis evaluation , contraindication glucagon administration ( pheochromocytoma , insulinoma malnourishment ) .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>